Today's News about Prescription Drugs
Spanberger Announces Support for Bipartisan Bill to Increase Competition in the Pharmaceutical Marketplace, Lower Prescription Drug Costs
Source: Abigail Spanberger (D-VA, 7th)
April 24, 2019
Spanberger is now a cosponsor of the Creating and Restoring Equal Access to Equivalent Samples (CREATES) Act of 2019, which would prohibit pharmaceutical companies from participating in certain anti-competitive practices that block cheaper generic drugs from entering that market. The bipartisan bill would increase competitive options for prescription drugs by cracking down on pharmaceutical companies’ ability to delay access to generic versions of expensive brand-name drugs.
Drug Take-back Day
Source: Trey Hollingsworth (R-IN, 9th)
April 24, 2019
The Drug Enforcement Administration's (DEA) National Prescription Drug Take-Back Day is this Saturday, April 27. From 10AM - 2PM, you can properly dispose of expired, unused, and unwanted prescription drugs to support ongoing efforts to combat the opioid epidemic that is facing our communities.
Cummings Releases Report on the Soaring Prices of Diabetes Drugs in his District
Source: Elijah Cummings (D-MD, 7th)
April 24, 2019
Congressman Elijah E. Cummings (D-MD), Chairman of the House Committee on Oversight and Reform, released a Committee Staff Report on the prices of diabetes drugs for seniors and the uninsured in Maryland’s 7th Congressional District. More than 30 million people in the United States, including more than one in four seniors, have diabetes. Patients with diabetes rely on prescription drugs, including insulin, to help manage their conditions.
Following Prescription Drug Roundtable, Rep. Davids Supports Bills to Lower Prescription Drug Costs
Source: Sharice Davids (D-KS, 3rd)
April 24, 2019
“During our roundtable discussion, I heard from so many families in the Third District who are struggling to pay for the prescription drugs that they or their loved ones depend on to survive. These bills would help drive down prescription drugs prices and increase transparency and oversight, giving our families some much-needed relief,” said Davids.
Cummings Releases Report on the Soaring Prices of Diabetes Drugs in his District
Source: Elijah Cummings (D-MD, 7th)
April 24, 2019
Congressman Elijah E. Cummings (D-MD), Chairman of the House Committee on Oversight and Reform, released a Committee Staff Report on the prices of diabetes drugs for seniors and the uninsured in Maryland’s 7th Congressional District. More than 30 million people in the United States, including more than one in four seniors, have diabetes. Patients with diabetes rely on prescription drugs, including insulin, to help manage their conditions.